Alkermes
leveraging alkermes molecular design capabilities to target dysfunction in narcolepsy | Alkermes
Company
Deck Type
Sector
Industry
Deck date
January 2022
Slide
32 of 36
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Conference
January 2024
dysfunction well defined opportunity in narcolepsy and other sleep disorders | Alkermes
Investor Presentation
June 2023
dysfunction well defined opportunity in narcolepsy and other sleep disorders | Alkermes
Investor Presentation
March 2023
dysfunction well defined opportunity in narcolepsy and other sleep disorders | Alkermes
Investor Presentation
January 2023
dysfunction well defined opportunity in narcolepsy and other sleep disorders | Alkermes
Related slides by other companies
23andMe
Investor Day
January 2022
leveraging our i signature implicates pathway | 23andMe
Melrose
Investor Presentation
May 2023
super tier capability grow reduce | Melrose
AstraZeneca
Investor Conference
April 2023
leveraging in house capabilities and technology to accelerate innovation a | AstraZeneca
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io